First Graphene Valuation

Is FGPH.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FGPH.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate FGPH.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate FGPH.F's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FGPH.F?

Key metric: As FGPH.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for FGPH.F. This is calculated by dividing FGPH.F's market cap by their current revenue.
What is FGPH.F's PS Ratio?
PS Ratio	43.6x
Sales	AU$492.00k
Market Cap	AU$21.43m

FGPH.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	44.5x
Enterprise Value/EBITDA	-5.1x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does FGPH.F's PS Ratio compare to its peers?

The above table shows the PS ratio for FGPH.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	3.4x
NNUP Nocopi Technologies	9.7x	n/a	US$17.9m
DNMR Danimer Scientific	0.4x	48.2%	US$15.7m
BON Bon Natural Life	0.2x	n/a	US$6.2m
NMGX Nano Magic	3.1x	n/a	US$7.9m
FGPH.F First Graphene	43.6x	n/a	US$21.4m

Price-To-Sales vs Peers: FGPH.F is expensive based on its Price-To-Sales Ratio (43.6x) compared to the peer average (3.4x).

Price to Sales Ratio vs Industry

How does FGPH.F's PS Ratio compare vs other companies in the US Chemicals Industry?

10 Companies	Price / Sales	Estimated Growth	Market Cap
TSE Trinseo	0.04x	5.0%	US$125.68m
ALTO Alto Ingredients	0.1x	3.1%	US$108.84m
BON Bon Natural Life	0.2x	n/a	US$6.23m
ABLT American Biltrite	0.02x	n/a	US$2.91m

10 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: FGPH.F is expensive based on its Price-To-Sales Ratio (43.6x) compared to the US Chemicals industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is FGPH.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FGPH.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	43.6x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate FGPH.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Trinseo

US$125.7m

Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.

TSE

US$3.55

2.6%

-45.6%

Nippon Sanso Holdings

JP¥1.9t

Engages in the gas business in Japan, the United States, Europe, Asia, and Oceania.

TYNP.F

JP¥29.18

-2.3%

8.7%

Allied Gold

CA$1.1b

Explores for and produces mineral deposits in Africa.

AAUC.F

CA$2.47

16.0%

-18.0%